TSX: MFI
www.mapleleaffoods.com
Maple Leaf Foods lays the foundation for a transformative year in 2025, delivers fourth quarter Adjusted EBITDA of $155 million and Adjusted EBITDA Margin of 12.5%
Records Earnings of $97 million for fiscal 2024
MISSISSAUGA, ON, Feb. 25, 2025 /PRNewswire/ - Maple Leaf Foods Inc. ("Maple Leaf Foods" or "the Company") (TSX: MFI) today reported its financial results for the fourth quarter and full year ended December 31, 2024.
"I am incredibly proud of our team's outstanding performance in closing out the year," said Curtis Frank, President and Chief Executive Officer of Maple Leaf Foods. "In the fourth quarter, sales grew by 4.3% year over year, Adjusted EBITDA rose to $155 million, and our Adjusted EBITDA Margin expanded by 240 basis points to 12.5%."
"With our CPG growth strategies proving resilient, our large-scale capital projects now behind us, and pork markets stabilizing at more normal levels, 2024 delivered the significant financial progress we anticipated," continued Mr. Frank. "Free Cash Flow grew by $296 million in the year, allowing us to rapidly deleverage our balance sheet and improve our Net Debt to Adjusted EBITDA ratio to 2.7x by year-end. All to say we are entering 2025 with strong momentum, setting the stage for a transformational year ahead."
"As we look to 2025, we have a clear path to drive mid-single-digit sales growth, achieve Adjusted EBITDA that meets or exceeds $634 million, and complete the spin-off of our pork business. More than ever Maple Leaf Foods is positioned for long-term success," concluded Mr. Frank.
Fourth Quarter 2024 Highlights
2024 Highlights
Laying Groundwork for a Transformational Year Ahead
Advancing the Creation of Two Independent Public Companies
Outlook
(i) | Refer to the section titled Non-IFRS Financial Measures in this news release. |
(ii) | Maple Leaf defines investment grade leverage as typically operating below 3.0x Net Debt to Trailing Twelve Months Adjusted EBITDA. |
Financial and Operating Highlights
As at or for the | ||||||||||||
Measure(i) (Unaudited) | Three months ended December 31, | Twelve months ended December 31, | ||||||||||
2024 | 2023 | Change | 2024 | 2023 | Change | |||||||
Sales(ii) | $ 1,237.1 | $ 1,186.0 | 4.3 % | $ 4,895.0 | $ 4,841.2 | 1.1 % | ||||||
Gross profit | $ 236.3 | $ 135.5 | 74.4 % | $ 780.0 | $ 451.4 | 72.8 % | ||||||
Selling, general and administrative expenses | $ 101.9 | $ 101.3 | 0.6 % | $ 437.1 | $ 405.1 | 7.9 % | ||||||
Earnings (Loss) | $ 53.5 | $ (9.3) | nm(iv) | $ 96.6 | $ (125.0) | nm(iv) | ||||||
Basic Earnings (Loss) per Share | $ 0.43 | $ (0.08) | nm(iv) | $ 0.79 | $ (1.03) | nm(iv) | ||||||
Adjusted Operating Earnings(iii) | $ 88.7 | $ 57.5 | 54.3 % | $ 293.4 | $ 193.2 | 51.8 % | ||||||
Adjusted EBITDA(iii) | $ 155.1 | $ 120.2 | 29.0 % | $ 553.2 | $ 427.6 | 29.4 % | ||||||
Adjusted EBITDA Margin(ii)(iii) | 12.5 % | 10.1 % | 240 bps | 11.3 % | 8.8 % | 250 bps | ||||||
Adjusted EBT(iii) | $ 60.7 | $ 16.4 | 270.1 % | $ 137.6 | $ 34.2 | 302.3 % | ||||||
Adjusted Earnings per Share(iii) | $ 0.38 | $ 0.08 | nm(iv) | $ 0.78 | $ 0.09 | nm(iv) | ||||||
Free Cash Flow(iii) | $ 129.8 | $ 63.4 | 104.7 % | $ 385.3 | $ 89.0 | 332.9 % | ||||||
Net Debt(iii) | $ 1,516.0 | $ 1,747.5 | (13.2) % |
(i) | All financial measures in millions of dollars except Basic and Adjusted Earnings per Share. |
(ii) | Amounts for 2023 have been adjusted to eliminate sales agreements that contained an expectation of repurchase, which had previously been reported as external sales. |
(iii) | Refer to the section titled Non-IFRS Financial Measures in this news release. |
(iv) | Not meaningful. |
During the year ended December 31, 2024, the Company announced an update to its strategic blueprint (the "Blueprint") that reflects the progress it has made toward achieving its Purpose and Vision and establishes the roadmap for the next chapter of how Maple Leaf Foods intends to deliver on these objectives.
As part of delivering on these objectives, the Company combined its Meat and Plant Protein businesses and aligned its organizational structure to focus on growth potential in key markets and drive operational efficiencies. As a result, in the first quarter of 2024, Maple Leaf Foods began to report its business and operational results as a consolidated protein company, and updated its strategic Adjusted EBITDA Margin target of 14% - 16% to include Plant Protein.
As a consolidated protein company, Maple Leaf Foods has two operating units: Prepared Foods and Pork, which represent on average approximately 75% and 25% of total Company revenue respectively. Prepared Foods combines the operations of prepared meats, plant protein, and poultry, which represent on average approximately 50%, 5% and 20% of total Company revenue respectively.
On July 9, 2024, Maple Leaf Foods announced its intention to separate into two independent public companies through a spin-off of Maple Leaf Foods' Pork Business. This separation is expected to be completed in the second half of 2025. Please refer to the Outlook section for further information.
Fourth Quarter 2024
Sales for the fourth quarter increased 4.3% to $1,237.1 million compared to $1,186.0 million last year. Prepared Foods sales increased by 4.6%, with prepared meats and poultry increasing 6.5% and 1.8% respectively which was partially offset by a decline in plant protein of 10.3%. The increase in prepared meats sales was driven by improved category mix and retail and foodservice volume growth, which was partially offset by increased trade promotions. The increase in poultry sales was driven by improved channel mix tied to retail volume growth and reduced industrial sales. Plant protein sales were negatively impacted by volume declines which remain largely in line with the overall plant protein category. Sales in the Pork operating unit increased 3.5% driven by volume growth related to an increase in the number of hogs processed, and favourable foreign exchange impacts.
Gross profit for the fourth quarter of 2024 was $236.3 million (gross margin of 19.1%) compared to $135.5 million (gross margin of 11.4%) last year. The improvement in gross profit was driven by realization of the remaining London poultry facility and Bacon Centre of Excellence project benefits and related reduction in start-up expenses, increase in mark to market valuation of biological assets, improved pork market conditions, volume growth in prepared meats, and realization of operational efficiencies, all of which were partially offset by the impact of increased trade promotions in the quarter.
Selling, General and Administrative ("SG&A") expenses for the fourth quarter of 2024 were $101.9 million consistent with $101.3 million last year.
Earnings for the fourth quarter of 2024 were $53.5 million ($0.43 earnings per basic share) compared to a loss of $9.3 million ($0.08 loss per basic share) last year. The increase was driven by improvements in gross profit as described above as well as lower interest expense all partly offset by income taxes on increased earnings. Earnings were also negatively impacted by increased restructuring charges related to organizational changes executed in the fourth quarter, fair value adjustments on investment properties, and transaction costs associated with the anticipated spin-off of the Pork Business, all of which are recorded outside of Adjusted Operating Earnings
Adjusted Operating Earnings for the fourth quarter of 2024 were $88.7 million compared to $57.5 million last year. The increase was driven by factors consistent with those noted above and also excluding the impact of unrealized mark to market valuation adjustments and start-up expenses.
Adjusted EBITDA for the fourth quarter was $155.1 million, compared to $120.2 million last year, driven by factors consistent with those noted above and also excluding the impact of unrealized mark to market valuation adjustments and start-up expenses.
Adjusted EBT for the fourth quarter of 2024 were $60.7 million compared to $16.4 million last year, driven by factors noted above.
Free Cash Flow for the fourth quarter of 2024 was $129.8 million compared to Free Cash Flow of $63.4 million in the prior year. Free Cash Flow increased significantly due to: improved earnings after the removal of non-cash items; income tax refunds; and lower restructuring payments.
Full Year 2024
Sales for 2024 were $4,895.0 million compared to $4,841.2 million last year, an increase of 1.1%. Prepared Foods sales increased by 1.8%, with an increase in prepared meats sales of 3.9% partially offset by declines in poultry and plant protein of 2.6% and 4.3% respectively. The increase in prepared meats sales was driven by volume growth and category mix in retail and foodservice supported by increases in trade promotions. The decrease in poultry sales was driven by the repatriation of production to the London poultry facility and higher internalization of poultry supply into prepared meats, partially offset by improved channel mix tied to retail volume growth. Plant protein sales were negatively impacted by volume declines which were in line with the overall plant protein category. Sales in the pork operating unit declined by 0.9% due to lower resale activity and unfavourable product mix, which were partially offset by favourable market pricing.
Gross profit for 2024 increased to $780.0 million (gross margin of 15.9%) compared to $451.4 million (gross margin of 9.3%) last year. The increase in gross profit was driven by improved pork market conditions, realization of the London poultry facility and Bacon Centre of Excellence project benefits and reductions in related start-up expenses, increase in mark to market valuation of biological assets, volume growth in prepared meats, and operational efficiencies, all of which were partially offset by the impact of increased trade promotions in the year. Gross profit for 2024 included start-up expenses of $20.6 million (2023: $122.3 million) associated with Construction Capital projects, which are excluded from the calculation of Adjusted Operating Earnings.
SG&A expenses for 2024 were $437.1 million compared to $405.1 million last year. The increase in SG&A expenses was primarily driven by higher variable compensation.
Adjusted Operating Earnings for 2024 were $293.4 million compared to $193.2 million last year, and Adjusted Earnings per Share for 2024 was $0.78 compared to $0.09 last year. The increase was driven by factors consistent with those noted above and also excluding the impact of unrealized mark to market valuation adjustments and start-up expenses.
Earnings for 2024 were $96.6 million ($0.79 earnings per basic share) compared to a loss of $125.0 million ($1.03 loss per basic share) last year. The increase in Earnings was driven by improvements in gross profit noted above, partly offset by variable compensation, income taxes on higher earnings, increased interest expense, as well as costs associated with the anticipated spin-off of the Pork Business. Costs associated with the anticipated spin-off are recorded outside of Adjusted EBITDA.
Adjusted EBITDA for 2024 were $553.2 million compared to $427.6 million last year, driven by factors consistent with those noted above. Adjusted EBITDA Margin for 2024 was 11.3% compared to 8.8% last year, also driven by factors consistent with those noted above.
Adjusted Earnings Before Taxes ("Adjusted EBT") for 2024 were $137.6 million compared to $34.2 million last year due to similar factors as noted above.
Free Cash Flow for 2024 was $385.3 million compared to Free Cash Flow of $89.0 million in the prior year. Free Cash Flow increased significantly due to: improved earnings after the removal of non-cash items; income tax refunds; and lower restructuring payments.
Net Debt as at December 31, 2024 was $1,516.0 million, a decrease of $231.4 million compared to the prior year. For discussion of changes in Net Debt see section 11. Cash Flow and Financing of the Company's Management's Discussion and Analysis for the year ended December 31, 2024 as filed on SEDAR+.
Note: Several items are excluded from the discussions of underlying earnings performance as they are not representative of ongoing operational activities. Refer to the section entitled Non-IFRS Financial Measures at the end of this news release for a description and reconciliation of all non-IFRS financial measures. |
Other Matters
On January 9, 2025, the Board of Directors approved an increase in the quarterly dividend from $0.22 per share to $0.24 per share, or $0.96 per share on an annual basis. With this increase, the dividend payment for the first quarter of 2025 will be $0.24 per common share, payable on March 31, 2025, to shareholders of record at the close of business on March 7, 2025. Unless indicated otherwise by the Company at or before the time the dividend is paid, the dividend will be considered an eligible dividend for the purposes of the "Enhanced Dividend Tax Credit System". The Company's Dividend Reinvestment Plan ("DRIP") permits eligible shareholders to direct their cash dividends to be reinvested in additional common shares of the Company. The Company is eliminating the 2% discount on the treasury shares issued under the DRIP starting with this 2025 first quarter dividend. Therefore, for shareholders who wish to reinvest their dividends under the DRIP, Maple Leaf Foods intends to issue common shares from treasury at a price equal to 100% of the weighted average closing price of the shares for the five trading days preceding the dividend payment date. Full details of the DRIP, including how to enroll in the program, are available at https://www.mapleleaffoods.com/.
Conference Call
A conference call will be held at 8:00 a.m. ET on February 25, 2025, to review Maple Leaf Foods' fourth quarter financial results. To participate in the call, please dial 416-945-7677 or 1-888-699-1199. For those unable to participate, playback will be made available an hour after the event at 289-819-1450 or 1-888-660-6345 (Passcode: 11841#).
A webcast of the fourth quarter conference call will also be available at: https://www.mapleleaffoods.com/investors/events-and-presentations/.
The Company's full audited consolidated financial statements ("Consolidated Financial Statements") and related Management's Discussion and Analysis are available on the Company's website and on SEDAR+ at www.sedarplus.ca.
An investor presentation related to the Company's fourth quarter financial results is available at www.mapleleaffoods.com under Presentations and Webcasts on the Investors page.
Outlook
Maple Leaf Foods is a leading protein company built on a powerful portfolio of brands, with a leading voice in sustainability and food security. The Company continues to execute against its strategic Blueprint, which defines how it intends to advance its vision to be the Most Sustainable Protein Company on Earth and deliver on its commercial and financial objectives. A key deliverable in 2025 is the execution of the previously announced spin-off of the Pork Business, unlocking value for all stakeholders by creating two robust, independent public companies: Maple Leaf Foods as a protein focused consumer packaged goods company, and Canada Packers as a leading global pork company. Until the spin-off is completed, the Company continues to look at its business on a holistic basis.
For the full year 2025, the Company expects:
Maple Leaf Foods recognizes that macro-economic factors continue to strongly influence the current operating environment, creating uncertainty and potential volatility. This has a number of implications for the Company's business, including the influence these dynamics have on consumer sentiment, supply chain activity, access to markets, barriers to trade, and foreign exchange rates. The Company leverages its data-driven insights to stay close to these evolving circumstances and is confident in the resilience of its brands, business model and strategy to manage through prevailing economic conditions. At the same time, it recognizes that its ability to deliver its 2025 guidance could be impacted by these conditions, including the impact of tariffs between Canada and the U.S. The Company is deploying additional resources to identify mitigation strategies, near-term potential executional opportunities to manage risk, and identify and capitalize on opportunities from shifting consumer sentiment in Canada to U.S. products and competitiveness of U.S. products given the relative exchange rate between the U.S. and Canada. Refer to section 23. Risk Factors in the Company's Management's Discussion and Analysis for the year ended December 31, 2024 as filed on SEDAR+.
(i) | Maple Leaf defines investment grade leverage as typically operating below 3.0x Net Debt to Trailing Twelve Months Adjusted EBITDA |
Non-IFRS Financial Measures
The Company uses the following non-IFRS measures: Adjusted Operating Earnings, Adjusted Earnings per Share, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted EBT, Construction Capital, Net Debt, Net Debt to Trailing Four Quarters Adjusted EBITDA, Free Cash Flow and Return on Net Assets. Management believes that these non-IFRS measures provide useful information to investors in measuring the financial performance of the Company for the reasons outlined below. These measures do not have a standardized meaning prescribed by IFRS and therefore they may not be comparable to similarly titled measures presented by other publicly traded companies and should not be construed as an alternative to other financial measures determined in accordance with IFRS.
Adjusted Operating Earnings, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted EBT
Adjusted Operating Earnings, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted EBT are non-IFRS measures used by Management to evaluate financial operating results. Adjusted Operating Earnings is defined as earnings before income taxes adjusted for items that are not considered representative of ongoing operational activities of the business and certain items where the economic impact of the transactions will be reflected in earnings in future periods when the underlying asset is sold or transferred. Adjusted EBITDA is defined as Adjusted Operating Earnings plus depreciation and intangible asset amortization, adjusted for items included in other expense that are considered representative of ongoing operational activities of the business. Adjusted EBITDA Margin is calculated as Adjusted EBITDA divided by sales. Adjusted EBT is used annually by the Company to evaluate its performance and is a component of calculating bonus entitlements under the Company's short term incentive plan. It is defined as Adjusted EBITDA plus interest income, less depreciation and amortization, and interest expense and other financing costs.
The tables below provide a reconciliation of earnings (loss) before income taxes as reported under IFRS in the Consolidated Financial Statements to Adjusted Operating Earnings, Adjusted EBITDA and Adjusted EBT for the year ended December 31, as indicated below. Management believes that these non-IFRS measures are useful in assessing the performance of the Company's ongoing operations and its ability to generate cash flows to fund its cash requirements, including the Company's capital investment program.
Three months | Three months | |
($ millions)(i) | Total | Total |
Earnings (loss) before income taxes | $ 74.4 | $ (8.7) |
Interest expense and other financing costs | 35.8 | 41.2 |
Other expense (income) | 11.9 | 0.9 |
Restructuring and other related costs | 12.4 | 0.8 |
Earnings from operations | $ 134.4 | $ 34.2 |
Start-up expenses from Construction Capital(iii) | 0.9 | 29.7 |
(Increase) decrease in fair value of biological assets | (43.2) | (8.9) |
(Increase) decrease in derivative contracts | (3.3) | 2.5 |
Adjusted Operating Earnings | $ 88.7 | $ 57.5 |
Depreciation and amortization(iii) | 63.5 | 63.6 |
Items included in other income (expense) representative of ongoing operations(iv) | 2.9 | (0.9) |
Adjusted EBITDA | $ 155.1 | $ 120.2 |
Adjusted EBITDA Margin(v) | 12.5 % | 10.1 % |
Interest expense and other financing costs | (35.8) | (41.2) |
Interest income | 4.8 | 1.1 |
Depreciation and amortization | (63.5) | (63.6) |
Adjusted EBT | $ 60.7 | $ 16.4 |
(i) | Totals may not add due to rounding. |
(ii) | Start-up expenses are temporary costs as a result of operating new facilities that are or were previously classified as Construction Capital. These costs can include training, product testing, yield and labour efficiency variances, duplicative overheads including depreciation and other temporary expenses required to ramp-up production. |
(iii) | Depreciation included in start-up expenses and restructuring and other related costs are excluded from this line. |
(iv) | Primarily includes certain costs associated with sustainability projects, gains and losses on the sale of long-term assets, legal settlements, and other miscellaneous expenses. |
(v) | Amounts for 2023 have been adjusted to eliminate sales agreements that contained an expectation of repurchase, which had previously been reported as external sales. |
Twelve months | Twelve months | |
($ millions)(i) | Total | Total |
Earnings (loss) before income taxes | $ 140.9 | $ (142.6) |
Interest expense and other financing costs | 162.6 | 150.9 |
Other expense | 19.5 | 14.4 |
Restructuring and other related costs | 19.9 | 23.7 |
Earnings from operations | $ 342.9 | $ 46.3 |
Start-up expenses from Construction Capital(ii) | 20.6 | 122.3 |
(Increase) decrease in fair value of biological assets | (63.6) | 19.6 |
(Increase) decrease in derivative contracts | (6.4) | 5.0 |
Adjusted Operating Earnings | $ 293.4 | $ 193.2 |
Depreciation and amortization(iii) | 260.7 | 246.7 |
Items included in other income (expense) representative of ongoing operations(iv) | (0.9) | (12.4) |
Adjusted EBITDA | $ 553.2 | $ 427.6 |
Adjusted EBITDA Margin(v) | 11.3 % | 8.8 % |
Interest expense and other financing costs | (162.6) | (150.9) |
Interest income | 7.6 | 4.2 |
Depreciation and amortization | (260.7) | (246.7) |
Adjusted EBT | $ 137.6 | $ 34.2 |
(i) | Totals may not add due to rounding. |
(ii) | Start-up expenses are temporary costs as a result of operating new facilities that are or were previously classified as Construction Capital. These costs can include training, product testing, yield and labour efficiency variances, duplicative overheads including depreciation and other temporary expenses required to ramp-up production. |
(iii) | Depreciation included in start-up expenses and restructuring and other related costs are excluded from this line. |
(iv) | Primarily includes certain costs associated with sustainability projects, gains and losses on the sale of long-term assets, legal settlements, and other miscellaneous expenses. |
(v) | Amounts for 2023 have been adjusted to eliminate sales agreements that contained an expectation of repurchase, which had previously been reported as external sales. |
Adjusted Earnings per Share
Adjusted Earnings per Share, a non-IFRS measure, is used by Management to evaluate financial operating results. It is defined as basic earnings per share and is adjusted on the same basis as Adjusted Operating Earnings. The table below provides a reconciliation of basic earnings per share as reported under IFRS in the Consolidated Financial Statements to Adjusted Earnings per Share for the three months and the years ended December 31, as indicated below. Management believes this basis is the most appropriate on which to evaluate financial results as they are representative of the ongoing operations of the Company.
($ per share) (Unaudited) | Three months ended December 31, | Twelve months ended December 31, | ||||||
2024 | 2023 | 2024 | 2023 | |||||
Basic earnings (loss) per share | $ 0.43 | $ (0.08) | $ 0.79 | $ (1.03) | ||||
Restructuring and other related costs(i) | 0.08 | — | 0.12 | 0.18 | ||||
Items included in other income (expense) not | 0.13 | 0.01 | 0.17 | 0.04 | ||||
Start-up expenses from Construction Capital(iii) | 0.01 | 0.18 | 0.12 | 0.75 | ||||
Change in fair value of biological assets | (0.24) | (0.05) | (0.38) | 0.12 | ||||
(Increase) decrease on | (0.02) | 0.02 | (0.04) | 0.03 | ||||
Adjusted Earnings per Share(iv) | $ 0.38 | $ 0.08 | $ 0.78 | $ 0.09 |
(i) | Includes per share impact of restructuring and other related costs, net of tax. |
(ii) | Primarily includes legal fees and settlements, gains or losses on investment property, and transaction related costs, net of tax. |
(iii) | Start-up expenses are temporary costs as a result of operating new facilities that are or were previously classified as Construction Capital. These costs can include training, product testing, yield and labour efficiency variances, duplicative overheads and other temporary expenses required to ramp-up production, net of tax. |
(iv) | Totals may not add due to rounding. |
Construction Capital
Construction Capital, a non-IFRS measure, is used by Management to evaluate the amount of capital resources invested in specific strategic development projects that are not yet operational. It is defined as investments and related financing charges in projects over $50.0 million that are related to longer-term strategic initiatives, with no returns expected for at least 12 months from commencement of construction and the asset is re-categorized from Construction Capital once operational. There were no Construction Capital projects during 2024 as all projects had been completed.
($ thousands) | 2023 | |
Property and equipment and intangibles at January 1 | $ 2,663,985 | |
Other capital and intangible assets at January 1(i) | 2,654,419 | |
Construction Capital at January 1 | $ 9,566 | |
Additions | 41,931 | |
Transfers from Construction Capital | (51,497) | |
Construction Capital at December 31 | $ — | |
Other capital and intangible assets at December 31(i) | 2,596,839 | |
Property and equipment and intangibles at December 31 | $ 2,596,839 | |
Construction Capital debt financing(ii) | $ — |
(i) | Other capital and intangible assets consists of property and equipment and intangibles that do not meet the definition of Construction Capital. |
(ii) | December 31, 2023 does not include $1,091.0 million in capital that has been transferred out but is still in the start-up stage. |
Net Debt
The following table reconciles Net Debt to amounts reported under IFRS in the Company's Consolidated Financial Statements and calculates the Net Debt to Adjusted EBITDA ratio as at December 31, as indicated below. The Company calculates Net Debt as cash and cash equivalents, less long-term debt and bank indebtedness, and calculates Net Debt to Adjusted EBITDA as the absolute value of Net Debt divided by Adjusted EBITDA. Management believes these measures are useful in assessing the amount of financial leverage employed.
As at December 31, | ||||
($ thousands) | 2024 | 2023 | ||
Cash and cash equivalents | $ 175,908 | $ 203,363 | ||
Current portion of long-term debt | $ (301,478) | $ (400,735) | ||
Long-term debt | (1,390,479) | (1,550,080) | ||
Total debt | $ (1,691,957) | $ (1,950,815) | ||
Net Debt | $ (1,516,049) | $ (1,747,452) | ||
Adjusted EBITDA | 553,224 | 427,588 | ||
Net Debt to Adjusted EBITDA | 2.7 | 4.1 |
Free Cash Flow
Free Cash Flow, a non-IFRS measure, is used by Management to evaluate cash flow after investing in the maintenance of the Company's asset base. It is defined as cash provided by operations, less Maintenance Capital(i) and associated interest paid and capitalized. The following table calculates Free Cash Flow for the periods indicated below:
($ thousands) | Three months ended December 31, | Twelve months ended December 31, | |||||||
2024 | 2023 | 2024 | 2023 | ||||||
Cash provided by operating activities | $ 155,904 | $ 83,012 | $ 464,920 | $ 176,883 | |||||
Maintenance Capital(i) | (25,862) | (19,235) | (78,571) | (86,602) | |||||
Interest paid and capitalized related to Maintenance Capital | (260) | (377) | (1,007) | (1,267) | |||||
Free Cash Flow | $ 129,782 | $ 63,400 | $ 385,342 | $ 89,014 |
(i) | Maintenance Capital is defined as non-discretionary investment required to maintain the Company's existing operations and competitive position. For the twelve months ended December 31, total capital spending of $95.5 million (2023: $198.2 million) shown on the Consolidated Statements of Cash Flows is made up of Maintenance Capital of $78.6 million (2023: $86.6 million), and Growth Capital of $16.9 million (2023: $111.6 million). For the three months ended December 31, total capital spending of $29.2 million (2023: $41.8 million) is made up of Maintenance Capital of $25.9 million (2023: $19.2 million), and Growth Capital of $3.3 million (2023: $22.6 million). |
Return on Net Assets ("RONA")
RONA is calculated by dividing tax effected earnings from operations (adjusted for items which are not considered representative of the underlying operations of the business) by average monthly net assets. Net assets are defined as total assets (excluding cash and deferred tax assets) less non-interest bearing liabilities (excluding deferred tax liabilities). Management believes that RONA is an appropriate basis upon which to evaluate long-term financial performance.
Forward-Looking Statements
This document contains, and the Company's oral and written public communications often contain, "forward-looking information" within the meaning of applicable securities law. These statements are based on current expectations, estimates, projections, beliefs, judgements and assumptions based on information available at the time the applicable forward-looking statement was made and in light of the Company's experience combined with its perception of historical trends. Such statements include, but are not limited to, statements with respect to objectives and goals, in addition to statements with respect to beliefs, plans, targets, goals, objectives, expectations, anticipations, estimates, and intentions. Forward-looking statements are typically identified by words such as "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "could", "would", "believe", "plan", "intend", "design", "target", "undertake", "view", "indicate", "maintain", "explore", "entail", "schedule", "objective", "strategy", "likely", "potential", "outlook", "aim", "propose", "goal", and similar expressions suggesting future events or future performance. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict.
By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. The Company believes the expectations reflected in the forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements should not be unduly relied upon.
Specific forward-looking information in this document may include, but is not limited to, statements with respect to:
Various factors or assumptions are typically applied by the Company in drawing conclusions or making the forecasts, projections, predictions or estimations set out in the forward-looking statements. These factors and assumptions are based on information currently available to the Company, including information obtained by the Company from third-party sources and include but are not limited to the following:
Readers are cautioned that these assumptions may prove to be incorrect in whole or in part. The Company's actual results may differ materially from those anticipated in any forward-looking statements.
Factors that could cause actual results or outcomes to differ materially from the results expressed, implied, or projected in the forward-looking statements contained in this document include, among other things, risks associated with the following:
The Company cautions readers that the foregoing list of factors is not exhaustive.
Readers are further cautioned that some of the forward-looking information, such as statements concerning future capital expenditures, Adjusted EBITDA expectations, Adjusted EBITDA Margin expansion, and the Company's ability to achieve its financial targets or projections may be considered to be financial outlooks for purposes of applicable securities legislation. These financial outlooks are presented to evaluate potential future earnings and anticipated future uses of cash flows and may not be appropriate for other purposes. Readers should not assume these financial outlooks will be achieved.
More information about risk factors can be found under the heading "Risk Factors" in the Company's Annual Management's Discussion and Analysis for the year ended December 31, 2024, that is available on SEDAR+ at www.sedarplus.ca. The reader should review such section in detail.
All forward-looking statements included herein speak only as of the date hereof. Unless required by law, the Company does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. All forward-looking statements contained herein are expressly qualified by this cautionary statement.
Management's Estimates on the Pork Business spin-off, and related Non-IFRS measures
The following table presents Management's preliminary estimates of certain financial information regarding Canada Packers and the business that will be retained after the separation by Maple Leaf Foods. These preliminary estimates have not been audited or reviewed by any third party, have been derived from internal management reporting, and reflect sales, cost and expense allocations, including with respect to corporate expenses, as well as other estimates and adjustments, each of which is preliminary in nature and subject to change.
Management believes that these preliminary estimates are useful in providing an indication of the relative size of the businesses upon separation. Each of these figures is expected to be refined prior to the separation, with full financial details to be presented in the management information circular to be filed in connection with the transaction.
Last twelve months ended December 31, 2024 | ||||||||
(in millions of Canadian dollars) (unaudited) | Canada | Maple Leaf | Eliminations | Consolidated | ||||
Sales (IFRS) | $ 1,658 | (ii) | $ 3,621 | (iii) | $ (384) | (iv) | $ 4,895 | (v) |
Adjusted EBITDA | $ 153 | (vi) | $ 400 | (vii) | — | $ 553 | (v),(viii) | |
Adjusted EBITDA Margin(ix) | 9.3 % | 11.0 % | — % | 11.3 % | ||||
Estimate of potential impact of separation* | ~ $(6) - (7) | ~$(4) - (5) | ||||||
Pro Forma Adjusted EBITDA(xi) | ~$145 | ~$395 | ||||||
Pro Forma Adjusted EBITDA margin(xii) | ~9% | ~11% | ||||||
Estimate of potential market normalization impact(xiii) | ~$45 -55 | |||||||
Pro Forma normalized Adjusted EBITDA(xiv) | ~$200 | |||||||
Pro Forma normalized Adjusted EBITDA Margin(xv) | ~12% |
Note: | |
(i) | Refers to the business that will be retained after the separation by Maple Leaf Foods Inc. |
(ii) | Represents management's preliminary estimate of sales (both to Maple Leaf Foods and to external third parties) attributable to the business that will be transferred to Canada Packers in the separation for the period presented. |
(iii) | Represents management's preliminary estimate of sales attributable to the business that will be retained by Maple Leaf Foods after the separation for the period presented. |
(iv) | Primarily represents management's preliminary estimate of sales from Canada Packers to Maple Leaf Foods for the period presented. |
(v) | The results reported are for the year ended December 31, 2024. |
(vi) | Represents management's preliminary estimate of the portion of consolidated Adjusted EBITDA attributable to Canada Packers for the period presented. As noted above, this estimate is subject to change and is expected to be refined prior to the separation. |
(vii) | Represents management's preliminary estimate of the portion of consolidated Adjusted EBITDA attributable to Maple Leaf Foods (as defined in note (i) above) for the period presented. As noted above, this estimate is subject to change and is expected to be refined prior to the separation. |
(viii) | For a definition of Adjusted EBITDA (consolidated), and a reconciliation of Adjusted EBITDA (consolidated) for the periods described in note (v) above to consolidated net income for such periods, see the Company's MD&A filed on SEDAR and SEDAR+ for the year ended December 31, 2024. |
(ix) | Defined as Adjusted EBITDA divided by Sales. This metric is subject to change and is expected to be refined prior to the separation in the same manner as the metrics from which this metric is derived, as noted above. |
* | Represents management's preliminary estimate of the potential impact on Adjusted EBITDA of Canada Packers and Maple Leaf Foods (as defined in note (i) above), respectively, if the separation had occurred on January 1, 2024. Primarily relates to management's preliminary estimate of (1) a change in Adjusted EBITDA of Canada Packers and an offsetting change in Adjusted EBITDA of Maple Leaf Foods as a result of the anticipated impact of the supply agreement and other contractual arrangements expected to be entered into in connection with the separation, (2) public company costs that would have been incurred by Canada Packers, and (3) a reallocation of certain SG&A expenses from Canada Packers to Maple Leaf Foods. As noted above, this estimate is subject to change and is expected to be refined prior to the separation. |
(xi) | Defined as Adjusted EBITDA plus management's preliminary estimate of the potential impact of the separation described in, and subject to the qualifications described in, note * above. |
(xii) | Defined as Pro Forma Adjusted EBITDA, as described in note (xi) above divided by Sales. This metric is subject to change and is expected to be refined prior to the separation in the same manner as the metrics from which this metric is derived, as noted above. |
(xiii) | Presented for illustrative purposes only, based on management estimates and assumptions, to indicate what the potential impact on Pro Forma Adjusted EBITDA may have been if market conditions during the period presented had reflected normal market conditions, defined as the 5-year pre-pandemic (2015 – 2019) average ("Normal Market Conditions"). Actual market conditions during the period presented were materially different from Normal Market Conditions, and there can be no assurance that actual Pro Forma Adjusted EBITDA would have been impacted in the manner shown if Normal Market Conditions had existed during the period presented, or that actual future market conditions will reflect Normal Market Conditions. This metric is not intended to be indicative of potential financial results for any future period. |
(xiv) | Defined as Pro Forma Adjusted EBITDA, as described in note (xi) above, plus management's preliminary estimate of the potential impact if market conditions during the period presented had reflected Normal Market Conditions, subject to the qualifications described in note (xiii) above. This metric is presented for illustrative purposes only and is not intended to be indicative of potential financial results for any future period. |
(xv) | Defined as Pro Forma normalized Adjusted EBITDA, as described in note (xiv) above, divided by Sales. This metric is presented for illustrative purposes only and is based on management estimates and assumptions. This metric is subject to change and is expected to be refined prior to the separation in the same manner as the metrics from which this metric is derived, as noted above. Actual market conditions during the period presented were materially different from Normal Market Conditions, and there can be no assurance that actual Pro Forma Adjusted EBITDA Margin would have been impacted in the manner shown if Normal Market Conditions had existed during the period presented, or that actual future market conditions will reflect Normal Market Conditions. This metric is not intended to be indicative of potential financial results for any future period. |
Adjusted EBITDA, Pro Forma Adjusted EBITDA, and Pro Forma normalized Adjusted EBITDA, and related margins, as presented in the table above, are non-IFRS metrics and do not have a standardized meaning prescribed by IFRS. Consequently, they may not be comparable to similarly titled measures presented by other publicly traded companies and should not be construed as an alternative to other financial measures determined in accordance with IFRS.
About Maple Leaf Foods Inc.
Maple Leaf Foods is a leading protein company responsibly producing food products under leading brands including Maple Leaf®, Maple Leaf Prime®, Maple Leaf Natural Selections®, Schneiders®, Mina®, Greenfield Natural Meat Co.®, Lightlife® and Field Roast™. The Company employs approximately 13,500 people and does business primarily in Canada, the U.S. and Asia. The Company is headquartered in Mississauga, Ontario and its shares trade on the Toronto Stock Exchange (MFI).
Consolidated Balance Sheets
(In thousands of Canadian dollars) (Audited) | As at December 31, | As at December 31, | ||
ASSETS | ||||
Cash and cash equivalents | $ 175,908 | $ 203,363 | ||
Accounts receivable | 170,919 | 183,798 | ||
Notes receivable | 37,978 | 33,220 | ||
Inventories | 553,398 | 542,392 | ||
Biological assets | 169,399 | 114,917 | ||
Income and other taxes recoverable | 7,551 | 88,896 | ||
Prepaid expenses and other assets | 42,342 | 44,865 | ||
Assets held for sale | 22,769 | — | ||
Total current assets | $ 1,180,264 | $ 1,211,451 | ||
Property and equipment | 2,123,167 | 2,251,710 | ||
Right-of-use assets | 160,922 | 154,610 | ||
Investments | 12,763 | 15,749 | ||
Investment property | 42,588 | 57,144 | ||
Employee benefits | 22,429 | 26,785 | ||
Other long-term assets | 24,918 | 22,336 | ||
Deferred tax asset | 46,588 | 40,854 | ||
Goodwill | 477,353 | 477,353 | ||
Intangible assets | 339,526 | 345,129 | ||
Total long-term assets | $ 3,250,254 | $ 3,391,670 | ||
Total assets | $ 4,430,518 | $ 4,603,121 | ||
LIABILITIES AND EQUITY | ||||
Accounts payable and accruals | $ 561,179 | $ 548,444 | ||
Current portion of provisions | 14,482 | 9,846 | ||
Current portion of long-term debt | 301,478 | 400,735 | ||
Current portion of lease obligations | 39,900 | 38,031 | ||
Income taxes payable | 2,595 | 2,382 | ||
Other current liabilities | 37,587 | 32,974 | ||
Total current liabilities | $ 957,221 | $ 1,032,412 | ||
Long-term debt | 1,390,479 | 1,550,080 | ||
Lease obligations | 147,892 | 142,286 | ||
Employee benefits | 62,395 | 64,196 | ||
Provisions | 3,912 | 2,041 | ||
Other long-term liabilities | 5,205 | 1,124 | ||
Deferred tax liability | 325,137 | 296,203 | ||
Total long-term liabilities | $ 1,935,020 | $ 2,055,930 | ||
Total liabilities | $ 2,892,241 | $ 3,088,342 | ||
Shareholders' equity | ||||
Share capital | $ 897,839 | $ 873,477 | ||
Retained earnings | 587,393 | 597,429 | ||
Contributed surplus | 12,482 | 3,227 | ||
Accumulated other comprehensive income | 43,994 | 47,829 | ||
Treasury shares | (3,431) | (7,183) | ||
Total shareholders' equity | $ 1,538,277 | $ 1,514,779 | ||
Total liabilities and equity | $ 4,430,518 | $ 4,603,121 |
Consolidated Statements of Earnings (Loss)
Three months ended December 31, | Twelve months ended December 31, | |||||||
(In thousands of Canadian dollars, except share amounts) | 2024 | 2023 | 2024 | 2023 | ||||
(Unaudited) | (Unaudited) | (Audited) | (Audited) | |||||
Sales(i) | $ 1,237,065 | $ 1,186,021 | $ 4,895,046 | $ 4,841,213 | ||||
Cost of goods sold | 1,000,766 | 1,050,545 | 4,115,040 | 4,389,839 | ||||
Gross profit | $ 236,299 | $ 135,475 | $ 780,006 | $ 451,374 | ||||
Selling, general and administrative expenses | 101,911 | 101,262 | 437,133 | 405,067 | ||||
Earnings before the following: | $ 134,388 | $ 34,213 | $ 342,873 | $ 46,307 | ||||
Restructuring and other related costs | 12,356 | 819 | 19,922 | 23,729 | ||||
Other expense (income) | 11,868 | 885 | 19,482 | 14,352 | ||||
Earnings before interest and income taxes | $ 110,164 | $ 32,509 | $ 303,469 | $ 8,226 | ||||
Interest expense and other financing costs | 35,793 | 41,227 | 162,600 | 150,851 | ||||
Earnings (loss) before income taxes | $ 74,371 | $ (8,718) | $ 140,869 | $ (142,625) | ||||
Income tax expense (recovery) | 20,835 | 602 | 44,270 | (17,649) | ||||
Earnings (loss) | $ 53,536 | $ (9,320) | $ 96,599 | $ (124,976) | ||||
Earnings (loss) per share attributable to common shareholders: | ||||||||
Basic (loss) earnings per share | $ 0.43 | $ (0.08) | $ 0.79 | $ (1.03) | ||||
Diluted (loss) earnings per share | $ 0.43 | $ (0.08) | $ 0.78 | $ (1.03) | ||||
Weighted average number of shares (millions): | ||||||||
Basic | 123.5 | 122.3 | 123.0 | 121.8 | ||||
Diluted | 124.6 | 122.3 | 124.3 | 121.8 |
(i) | Amounts for 2023 have been adjusted to eliminate sales agreements that contained an expectation of repurchase, which had previously been reported as external sales. |
Consolidated Statements of Other Comprehensive Income (Loss)
(In thousands of Canadian dollars) | Three months ended December 31, | Twelve months ended December 31, | ||||||
2024 | 2023 | 2024 | 2023 | |||||
(Unaudited) | (Unaudited) | (Audited) | (Audited) | |||||
Earnings (loss) | $ 53,536 | $ (9,320) | $ 96,599 | $ (124,976) | ||||
Other comprehensive income (loss) | ||||||||
Actuarial (losses) gains that will not be reclassified to profit or loss (Net of tax of $0.0 million and $0.6 million; 2023: $6.6 million and $4.4 million) | $ (6,885) | $ (19,580) | $ 1,908 | $ 12,313 | ||||
Change in revaluation surplus (Net of tax of $0.0 and $0.0 million; 2023: $6.4 million and $10.6 million) | $ — | $ 22,782 | $ — | $ 40,815 | ||||
Total items that will not be reclassified to profit or loss | $ (6,885) | $ 3,202 | $ 1,908 | $ 53,128 | ||||
Items that are or may be reclassified subsequently to profit or loss: | ||||||||
Change in fair value of investments (Net of tax of $0.0 million and $0.0 million; 2023: $0.0 million and $0.0 million) | $ (4,082) | $ (5,504) | $ (4,082) | $ (5,504) | ||||
Change in accumulated foreign currency translation adjustment (Net of tax of $0.0 million and $0.0 million; 2023: $0.0 million and $0.0 million) | 22,727 | (8,759) | 30,157 | (8,939) | ||||
Change in foreign exchange on long-term debt designated as a net investment hedge (Net of tax of $0.0 million and $4.5 million; 2023: $1.3 million and $1.2 million) | (17,885) | 7,194 | (24,237) | 6,592 | ||||
Change in cash flow hedges (Net of tax of $0.0 million and $0.9 million; 2023: $1.3 million and $3.9 million) | (1,293) | (2,091) | (5,673) | (8,469) | ||||
Total items that are or may be reclassified subsequently to profit or loss | $ (533) | $ (9,160) | $ (3,835) | $ (16,320) | ||||
Total other comprehensive (loss) income | $ (7,418) | $ (5,958) | $ (1,927) | $ 36,808 | ||||
Comprehensive income (loss) | $ 46,118 | $ (15,278) | $ 94,672 | $ (88,168) |
Consolidated Statements of Changes in Total Equity
Accumulated other comprehensive income (loss) | |||||||||
(In thousands of Canadian dollars) | Share capital | Retained earnings | Contributed surplus | Foreign | Unrealized gains and losses on cash flow hedges(i) | Unrealized | Revaluation | Treasury | Total equity |
Balance at December 31, 2023 | $ 873,477 | 597,429 | 3,227 | 8,625 | 4,416 | (2,559) | 37,347 | (7,183) | $ 1,514,779 |
Earnings | — | 96,599 | — | — | — | — | — | — | 96,599 |
Other comprehensive income (loss)(ii) | — | 1,908 | — | 5,920 | (5,673) | (4,082) | — | — | (1,927) |
Dividends declared ($0.88 per share) | 21,864 | (108,543) | — | — | — | — | — | — | (86,679) |
Share-based compensation expense | — | — | 21,910 | — | — | — | — | — | 21,910 |
Deferred taxes on share-based compensation | — | — | (1,325) | — | — | — | — | — | (1,325) |
Exercise of stock options | 2,498 | — | — | — | — | — | — | — | 2,498 |
Settlement of share-based compensation | — | — | (11,330) | — | — | — | — | 3,752 | (7,578) |
Balance at December 31, 2024 | $ 897,839 | 587,393 | 12,482 | 14,545 | (1,257) | (6,641) | 37,347 | (3,431) | $ 1,538,277 |
Accumulated other comprehensive income (loss) | |||||||||
(In thousands of Canadian dollars) | Share capital | Retained earnings | Contributed surplus | Foreign | Unrealized | Unrealized | Revaluation surplus | Treasury | Total |
Balance at December 31, 2022 | $ 850,086 | 809,616 | — | 10,972 | 12,885 | 2,945 | 2,745 | (25,916) | $ 1,663,333 |
Loss | — | (124,976) | — | — | — | — | — | — | (124,976) |
Other comprehensive income (loss)(ii) | — | 12,313 | — | (2,347) | (8,469) | (5,504) | 40,815 | — | 36,808 |
Dividends declared ($0.84 per share) | 10,178 | (102,722) | — | — | — | — | — | — | (92,544) |
Share-based compensation expense | — | — | 11,979 | — | — | — | — | — | 11,979 |
Deferred taxes on share-based compensation | — | — | 1,100 | — | — | — | — | — | 1,100 |
Exercise of stock options | 7,395 | — | (1,363) | — | — | — | — | — | 6,032 |
Shares re-purchased | (4,498) | — | (11,595) | — | — | — | — | — | (16,093) |
Sale of investment property | — | 6,213 | — | — | — | — | (6,213) | — | — |
Sale of treasury stock | — | — | — | — | — | — | — | 9,841 | 9,841 |
Settlement of share-based compensation | 1,305 | (3,015) | (17,883) | — | — | — | — | 8,892 | (10,701) |
Change in obligation for repurchase of shares | 9,011 | — | 20,989 | — | — | — | — | — | 30,000 |
Balance at December 31, 2023 | $ 873,477 | 597,429 | 3,227 | 8,625 | 4,416 | (2,559) | 37,347 | (7,183) | $ 1,514,779 |
(i) | Items that are or may be subsequently reclassified to profit or loss. |
(ii) | Included in other comprehensive income (loss) is the change in actuarial gains and losses that will not be reclassified to profit or loss and has been reclassified to retained earnings. |
Consolidated Statements of Cash Flows
(In thousands of Canadian dollars) | Three months ended December 31, | Twelve months ended December 31, | ||||||
2024 | 2023 | 2024 | 2023 | |||||
CASH PROVIDED BY (USED IN): | (Unaudited) | (Unaudited) | (Audited) | (Audited) | ||||
Operating activities | ||||||||
Earnings | $ 53,536 | $ (9,320) | $ 96,599 | $ (124,976) | ||||
Add (deduct) items not affecting cash: | ||||||||
Change in fair value of biological assets | (43,210) | (8,852) | (63,582) | 19,556 | ||||
Depreciation and amortization | 64,883 | 67,394 | 265,173 | 271,394 | ||||
Share-based compensation | 4,296 | 4,246 | 21,910 | 11,979 | ||||
Deferred income tax expense | 17,738 | 75,126 | 30,651 | 86,959 | ||||
Current income tax expense (recovery) | 3,097 | (74,524) | 13,619 | (104,608) | ||||
Interest expense and other financing costs | 35,793 | 41,227 | 162,600 | 150,851 | ||||
Gain on sale of long-term assets | (6,466) | (2,451) | (9,299) | (516) | ||||
Impairment of property and equipment and right-of-use assets | 538 | 15 | 667 | 9,011 | ||||
Impairment of investments | — | 1,953 | — | 1,953 | ||||
Change in fair value of long-term assets | 10,707 | — | 5,669 | — | ||||
Change in fair value of non-designated derivatives | (257) | 2,160 | (3,334) | (4,632) | ||||
Change in net pension obligation | 1,953 | 168 | 5,063 | 2,400 | ||||
Net income taxes refunded | 31,197 | 42,039 | 75,712 | 39,028 | ||||
Interest paid, net of capitalized interest | (34,926) | (41,614) | (148,925) | (150,425) | ||||
Change in provision for restructuring and other related costs | 8,025 | (4,590) | 6,570 | (33,542) | ||||
Change in derivatives margin | (2,764) | (2,425) | 2,235 | (6,409) | ||||
Cash settlement of derivatives | 2,878 | (2,036) | — | 3,361 | ||||
Other | (10,255) | 275 | (3,165) | (5,617) | ||||
Change in non-cash operating working capital | 19,141 | (5,779) | 6,757 | 11,116 | ||||
Cash provided by operating activities | $ 155,904 | $ 83,012 | $ 464,920 | $ 176,883 | ||||
Investing activities | ||||||||
Additions to long-term assets | $ (29,205) | $ (41,786) | $ (95,489) | $ (198,181) | ||||
Interest paid and capitalized | (289) | (485) | (1,128) | (2,969) | ||||
Proceeds from sale of long-term assets | 8,433 | 7,515 | 14,081 | 18,039 | ||||
Purchase of investments | — | — | — | (200) | ||||
Payment of legal settlement | — | (5,256) | — | (5,256) | ||||
Cash used in investing activities | $ (21,061) | $ (40,012) | $ (82,536) | $ (188,567) | ||||
Financing activities | ||||||||
Dividends paid | $ (21,803) | $ (20,632) | $ (86,679) | $ (92,544) | ||||
Net (decrease) increase in long-term debt | (110,893) | (15,937) | (290,981) | 253,064 | ||||
Payment of lease obligation | (8,026) | (8,223) | (32,353) | (32,951) | ||||
Exercise of stock options | — | 603 | 2,498 | 6,032 | ||||
Repurchase of shares | — | — | — | (16,093) | ||||
Payment of financing fees | — | (46) | (2,324) | (3,378) | ||||
Sale of treasury shares | — | — | — | 9,841 | ||||
Cash (used in) provided by financing activities | $ (140,722) | $ (44,235) | $ (409,839) | $ 123,971 | ||||
(Decrease) increase in cash and cash equivalents | (5,879) | (1,235) | (27,455) | 112,287 | ||||
Cash and cash equivalents, beginning of period | 181,787 | 204,598 | 203,363 | 91,076 | ||||
Cash and cash equivalents, end of period | $ 175,908 | $ 203,363 | $ 175,908 | $ 203,363 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/maple-leaf-foods-reports-fourth-quarter-and-full-year-2024-financial-results-302384552.html
SOURCE Maple Leaf Foods Inc.